Gene therapy cost-effective for treating sickle cell disease in simulation models
1. In this cost analysis, compared to standard care, it was found that gene therapy for sickle...
Read MoreFeb 7, 2024
1. In this cost analysis, compared to standard care, it was found that gene therapy for sickle...
Read MoreFeb 6, 2024
1. Diabetes remission was achievable for participants through weight loss by surgery or lifestyle...
Read MoreFeb 6, 2024
1. This randomized clinical trial demonstrated that compared with the standard of care,...
Read MoreFeb 6, 2024
1. Adding subcutaneous daratumumab to VRd (bortezomib, lenalidomide, and dexamethasone)...
Read MoreFeb 6, 2024
1. The objective response rate was 28% with a complete response of 5.6% and a partial response of...
Read MoreFeb 6, 2024
1. When comparing cohorts of patients above and below 75 years of age, hypertension had a greater...
Read MoreFeb 5, 2024
1. Moderately or late preterm infants were found to have an increased risk of neurological...
Read MoreFeb 5, 2024
1. 92.4% of children in high-income countries had heterozygous familial hypercholesterolemia...
Read MoreFeb 5, 2024
1. A cohort study found that increased maternal autistic traits were associated with a greater...
Read MoreFeb 3, 2024
1. In this randomized controlled trial, the incidence of death was lower in heart failure patients...
Read MoreFeb 2, 2024
1. In this randomized controlled trial, patients with transthyretin (TTR) amyloid cardiomyopathy...
Read MoreFeb 1, 2024
1. The Atezolizumab group demonstrated significantly greater progression-free and overall survival...
Read MoreFeb 1, 2024
1. Women with non-screen detected ductal carcinoma in situ had worse outcomes for the 25 years...
Read MoreJan 31, 2024
1. There was no procedure-related mortality or life-threatening events reported. 2. At the 6-month...
Read MoreJan 30, 2024
1. While perceived appetite did not differ between study groups, patients receiving mirtazapine...
Read MoreJan 30, 2024
1. Low dose Olanzapine (2.5 mg) demonstrated similar anti-emetic effect to standard dose...
Read MoreJan 30, 2024
1. There was no kidney rejection noted in the cemiplimab for kidney transplant recipients. 2....
Read MoreJan 26, 2024
1. Absence of moderate or severe headache 24 hours following administration of treatment drug was...
Read MoreJan 25, 2024
1. This longitudinal prospective cohort study found that older adults with trajectories involving...
Read MoreJan 25, 2024
1. Patients in the pembrolizumab plus chemotherapy group reported a significantly greater overall...
Read More